Italy; packages of branded drugs, which became off patent, sold in 2016
This statistic depicts the number of packages of branded drugs, supposed to become off patent in 2017, sold in Italy in 2016. According to data, Rosuvastatina was the branded medicine most popular, with approximately 5.5 million of packages sold. Among the branded drugs, that were about to lose their patent, Bosentan was the one with the lowest number of boxes sold.